Nanoparticles and microparticles for drug and vaccine delivery

Journal of Anatomy

Volumn 189, Issue 3, 1996, Pages 502-505

  Kreuter, J ^a  

^a GOETHE UNIVERSITY   (Germany)

Author keywords

Blood brain barrier; Gastrointestinal tract; Peyer's patches

Indexed keywords

ANTIGEN; DRUG CARRIER; NANOPARTICLE; PEPTIDE; POLYSORBATE 80; VACCINE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; BLOOD BRAIN BARRIER; CHEMICAL BOND; COMPARATIVE STUDY; CONFERENCE PAPER; DRUG BIOAVAILABILITY; DRUG DELIVERY SYSTEM; INTRAVENOUS DRUG ADMINISTRATION; LIQUID; MOUSE; NONHUMAN; PARTICLE SIZE; PEYER PATCH; PRIORITY JOURNAL; SOLID STATE; VACCINATION;

ADMINISTRATION, ORAL; DRUG CARRIERS; DRUG DELIVERY SYSTEMS; HUMANS; INTESTINAL ABSORPTION; MICROSPHERES; PEYER'S PATCHES; VACCINES;

EID: 0030448509     PISSN: 00218782     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. ALYAUTDIN R, GOTHIER D, PETROV V, KHARKEVICH D, KREUTER J (1995) Analgesic activity of the hexapeptide dalargin adsorbed on the surface of polysorbate 80-coated poly(butyl cyanoacrylate) nanoparticles. European Journal of Pharmaceutics and Biopharmaceutics 41, 44-48.
2. BECK P, KREUTER J, RESZKA R, FICHTNER I (1993) Influence of polybutylcyanoacrylate nanoparticles and liposomes on the efficacy and toxicity of the anticancer drug mitoxantrone in murine tumour models. Journal of Microencapsulation 10, 101-114.
3. BECK PH, KREUTER J, MÜLLER WEG, SCHATTON W (1994) Improved peroral delivery of avarol with polybutylcyanoacrylate nanoparticles. European Journal of Pharmaceutics and Biopharmaceutics 40, 134-137.
4. BORCHARD G, AUDUS KL, SHI F, KREUTER J (1994) Uptake of surfactant-coated poly(methyl methacrylate) nanoparticles by bovine brain microvessel endothelial cell monolayers. International Journal of Pharmaceutics 110, 29-35.
5. CAPPEL MJ, KREUTER J (1991) Effect of nanoparticles on transdermal drug delivery. Journal of Microencapsulation 8, 369-374.
6. DAMGÉ C, MICHEL C, APRAHAMIAN M, COUVREUR P (1988) New approach for oral administration of insulin with polyalkylcyanoacrylate nanocapsules as drug carrier. Diabetes 37, 246-251.
7. DEASY PB (1984) Microencapsulation and Related Drug Processes. New York: M. Dekker.
8. DONBROW M (1992) Microcapsules and Nanoparticles in Medicine and Pharmacy. Boca Raton: CRC Press.
9. ELDRIDGE JH, HAMMOND CJ, MEULBROEK JA, STAAS JK, GILLEY RM, TICE TR (1990) Controlled vaccine release in the gutassociated lymphoid tissues. I. Orally administered biodegradable microspheres target the Peyer's patches. Journal of Controlled Release 11, 205-214.
10. GREF R, MINAMITAKE Y, PERACCHIA MT, TRUBETSKOY V, TORCHTLIN V, LANGER R (1994) Biodegradable long-circulating polymeric nanospheres. Science 263, 1600-1603.
11. JAM P, HALBERT GW, LANGRIDGE J, FLORENCE AT (1989) The uptake and translocation of latex nanospheres and microspheres after oral administration to rats. Journal of Pharmacy and Pharmacology, 41, 809-812.
12. JAM P, HALBERT GW, LANGRIDGE J, FLORENCE AT (1990) Nanoparticle uptake by the rat gastrointestinal mucosa: quantitation and particle size dependency. Journal of Pharmacy and Pharmacology 42, 821-826.
13. KREUTER J (1983) Solid dispersion and solid solution. In Topics in Pharmaceutical Sciences (ed. Breimer DD, Speiser P), pp. 359-370. Amsterdam: Elsevier.
14. KREUTER J (1991) Peroral administration of nanoparticles. Advanced Drug Delivery Reviews 7, 71-86.
15. KREUTER J (1994a) Nanoparticles. In Colloidal Drug Delivers Systems (ed. Kreuter J), pp. 219-342. New York: M. Dekker.
16. KREUTER J (1994b) Nanoparticles. In Encyclopedia of Pharmaceutical Technology, vol. 10 (ed. Swarbrick J, Boylan JC), pp. 165-190, New York: M. Dekker.
17. 75Se) norcholestenol. International Journal of Pharmaceutics 16, 105-113.
18. KREUTER J, ALYAUTDIN RN, KHARKEVICH DA, IVANOV AA (1995) Passage of peptides through the blood-brain-barrier with colloidal particles (nanoparticles). Brain Research 674, 171-174.
19. MAINCENT P, LE VERGE R, SADO P, COUVREUR P, DEVISSAGUET JP (1986) Disposition kinetics and oral bioavailability of vincamine-loaded polyalkyl cyanoacrylate nanoparticles. Journal of Pharmaceutical Sciences 75, 955-958.
20. MAINCENT P, THOUVENOT P, AMICABILE C, HOFFMANN M, KREUTER J, COUVREUR P et al. (1992) Lymphatic targeting of polymeric nanoparticles after intraperitoneal administration in rats. Pharmaceutical Research 9, 1534-1539.
21. MICHEL C, APRAHAMIAN M, DEFONTAINE L, COUVREUR P, DAMGÉ C (1991) The effect of site of administration in the gastrointestinal tract on the absorption of insulin from nanoparticles in diabetic rats. Journal of Pharmacy and Pharmacology 43, 1-5.
22. NIXON JR (1976) Microencapsulation. New York: M. Dekker,
23. SCHÄFER VM, VON BRIESEN H, ANDREESEN R, STEFFAN A-M, ROYER C, TRÖSTER S et al. (1992) Phagocytosis of nanoparticles by human immunodeficiency virus (HIV)-infected macrophages: a possibility for antiviral drug targeting. Pharmaceutical Research 9, 541-546.
24. TRÖSTER SD, MÜLLER U, KREUTER J (1990) Modification of the body distribution of poly(methyl methacrylate) nanoparticles in rats by coating with surfactants. International Journal of Pharmaceutics 61, 85-100.